HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Event-Driven

Greatview Aseptic Packaging / Event-Driven

<ul>
<li>The loss of control over Greatview's international business will lead to significant loss of Newjf’s interests,which is the most direct trigger of Newjf’s decision to initiate an acquisition of Greatview.</li>
<li>Newjf is actively fulfilling the Pre-Conditions and is now progressing smoothly. Newjf’s acquisition of Greatview is complied with the Anti-monopoly Law. Newjf will make every effort to complete the acquisition. </li>
<li>Greatview urges shareholders to reject Newjf's Offer is not for the benefit of the entire company. The “true motives” behind are questionable. We advise investors to take Newjf’s Offer seriously.</li>
</ul>


The loss of control over Greatview's international business will lead to significant loss of Newjf’s interests,which is the most direct trigger of Newjf’s decision to initiate an acquisition of Greatview.
Newjf is actively fulfilling the Pre-Conditions and is now progressing smoothly. Newjf’s acquisition of Greatview is complied with the Anti-monopoly Law. Newjf will make every effort to complete the acquisition. 
Greatview urges shareholders to reject Newjf's Offer is not for the benefit of the entire company. The “true motives” behind are questionable. We advise investors to take Newjf’s Offer seriously.


Greatview Aseptic Packaging (468.HK) Update - Some New Information Worth the Attention

External broker reports(aggregated public sources), CMB International

CMB International

External broker reports(aggregated public sources)

Incorporated in Hong Kong, supported by the mainland and targeting in global market, CMB International Capital Corporation Limited (“CMBI”) is an integrated financial institution providing comprehensive and professional services. As a wholly-owned subsidiary of China Merchants Bank ("CMB"), by leveraging on the Group’s synergy and coordination in domestic and overseas markets, as well as CMB’s strong resources and outstanding social reputation, CMBI and its subsidiaries have been actively implementing diversified business strategies and set up an overall layout of main business segments including Corporate Finance, Asset Management, Wealth Management, Global Markets and Structured Finance, etc. Adhering to the philosophy of “being clients oriented and increasing our own values by the way of creating value for clients”, CMBI endeavors to provide quality and integrated financial services to institutional, corporate and individual customers both domestic and overseas including Hong Kong IPO sponsorship and underwriting, share placement and rights issue for listed companies, financial advisors, bonds issuance services, asset management, direct investment, wealth management, equity sales and trading, etc.

Equity Bottom-Up

Inner Mongolia Yili Industrial Group (A) / Equity Bottom-Up

<ul><li>We forecast Yili’s 4Q revenue/net profit to reach RMB30.7bn/1.1bn.</li><li>Excluding Ausnutria, of which we forecast a LSD sales decline, we expect recurring revenue to grow MSD% YoY.</li><li>This will be predominately composed of: 1) HSD growth in basic white milk, for which premiumization momentum drives Satine to grow by double digits; 2) LSD growth in milk powder, for which adult formula to grow by double digits. On the flip side, headwinds prevail in a few segments that balance out the strength. </li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

We forecast Yili’s 4Q revenue/net profit to reach RMB30.7bn/1.1bn.Excluding Ausnutria, of which we forecast a LSD sales decline, we expect recurring revenue to grow MSD% YoY.This will be predominately composed of: 1) HSD growth in basic white milk, for which premiumization momentum drives Satine to grow by double digits; 2) LSD growth in milk powder, for which adult formula to grow by double digits. On the flip side, headwinds prevail in a few segments that balance out the strength. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Yili (600887 CH) - 4Q Preview: Rev/Np Reach RMB30.7bn/1.1bn

Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

<ul>
<li>Back on the 27 January 2023, <a href="https://www.smartkarma.com/entities/jardine-matheson-holdings-ltd" target="_blank" data-smartkarma-citation="entities:19718:1" rel="noopener">Jardine Matheson (JM SP)</a> entered an agreement with <a href="https://www.smartkarma.com/entities/shandong-xinjufeng-technology-packaging-co-ltd" target="_blank" data-smartkarma-citation="entities:36744:1" rel="noopener">Shandong Xinjufeng (301296 CH)</a> (XJF) to sell its 28.22% stake in <a href="https://www.smartkarma.com/entities/greatview-aseptic-packaging" target="_blank" data-smartkarma-citation="entities:10802:1" rel="noopener">GAPack (468 HK)</a>. </li>
<li>That sale completed in September.  Last week, XJF requisitioned an EGM to consider appointing five new (&amp; friendly) directors, all-but taking control of the board. </li>
<li>CEO and founder Jeff Bi holds 9.65%. The question is: what are his options?</li>
</ul>


Back on the 27 January 2023, Jardine Matheson (JM SP) entered an agreement with Shandong Xinjufeng (301296 CH) (XJF) to sell its 28.22% stake in GAPack (468 HK). 
That sale completed in September.  Last week, XJF requisitioned an EGM to consider appointing five new (&amp; friendly) directors, all-but taking control of the board. 
CEO and founder Jeff Bi holds 9.65%. The question is: what are his options?


GAPack (468 HK): Unpacking XJF's Move To Send The Board Packing

HK/China Equity Long-Short

Osbert Tang, CFA

Thematic (Sector/Industry)

<ul>
<li>Disappointing FY22 result from raw milk company <a href="https://www.smartkarma.com/entities/austasia-group-ltd" target="_blank" data-smartkarma-citation="entities:36655:1" rel="noopener">AustAsia Group (2425 HK)</a> should be well expected, but the issue is its guidance that FY23 industry outlook will stay challenging. </li>
<li>Raw milk price is still coming down and 1H23 dairy product demand recovery is slow. Capacity influx will disrupt demand-supply balance, but feed costs pressure seems to have moderated. </li>
<li>Consensus profit projections for the sector are overly optimistic and there is earnings downgrade risk after FY22 result announcement. We will shy away in the near term.</li>
</ul>


Disappointing FY22 result from raw milk company AustAsia Group (2425 HK) should be well expected, but the issue is its guidance that FY23 industry outlook will stay challenging. 
Raw milk price is still coming down and 1H23 dairy product demand recovery is slow. Capacity influx will disrupt demand-supply balance, but feed costs pressure seems to have moderated. 
Consensus profit projections for the sector are overly optimistic and there is earnings downgrade risk after FY22 result announcement. We will shy away in the near term.


China Raw Milk Industry: Takeaways from AustAsia (2425 HK) Call

<ul>
<li>Earlier this year, <a href="https://www.smartkarma.com/entities/jardine-matheson-holdings-ltd" target="_blank" data-smartkarma-citation="entities:19718:1" rel="noopener">Jardine Matheson Holdings (JM SP)</a> was understood to be exploring the sale of its 28% stake in <a href="https://www.smartkarma.com/entities/greatview-aseptic-packaging" target="_blank" data-smartkarma-citation="entities:10802:1" rel="noopener">Greatview Aseptic Packaging (468 HK)</a>.</li>
<li>GA Pack announced its full-year results late last month and for the first time since 2012, opted not to pay a final dividend.</li>
<li>Shares are down 20% since that non-dividend announcement. That's convenient.</li>
</ul>


Earlier this year, Jardine Matheson Holdings (JM SP) was understood to be exploring the sale of its 28% stake in Greatview Aseptic Packaging (468 HK).
GA Pack announced its full-year results late last month and for the first time since 2012, opted not to pay a final dividend.
Shares are down 20% since that non-dividend announcement. That's convenient.


China

Inner Mongolia Yili Industrial Group Co., Ltd. produces milk, powdered milk, ice cream, and other dairy products.  The Company also produces frozen food and noodles.

Inner Mongolia Yili Industrial Group (A) (600887 CH)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Inner Mongolia Yili Industrial Group (A) (600887 CH)

Greatview Aseptic Packaging (468.HK) Update - Some New Information Worth the Attention

The merger control filing with the Anti-trust Bureau of SAMR has been completed. NewJF also continues to liaise actively with the other competent...

Xinyao (Criss) Wang

Yili (600887 CH) - 4Q Preview: Rev/Np Reach RMB30.7bn/1.1bn

We forecast Yili’s 4Q revenue/net profit to reach RMB30.7bn/1.1bn. Excluding Ausnutria, of which we forecast a LSD sales decline, we expect...

CMB International

GAPack (468 HK): Unpacking XJF's Move To Send The Board Packing

Nothing like bringing one of your customers - China Mengniu - on board (so to speak), both as a substantial shareholder (5.01%) and board member...

David Blennerhassett

China Raw Milk Industry: Takeaways from AustAsia (2425 HK) Call

Outlook for the raw milk industry stays challenging in FY23. Raw milk price is still coming down, 1H23 dairy product demand recovery is slow and...

Osbert Tang, CFA

Greatview (468 HK): A Packing Case Pick

I'd be picking up shares here. Pegged to its longer-term EV/EBITDA average, there is ~50%+ upside from here. With even more upside if GA Pack is...

David Blennerhassett

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)